Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.

CONCLUSIONS: Neither aspirin nor folic acid treatment had a statistically significant effect on BCC risk. Subgroup analysis by skin cancer history suggested that chemopreventive effects of nonsteroidal anti-inflammatory drugs observed in previous studies may be specific to those at high risk for BCC. This article is protected by copyright. All rights reserved.
PMID: 29570772 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - March 23, 2018 Category: Dermatology Authors: Passarelli MN, Barry EL, Zhang D, Gangar P, Rees JR, Bresalier RS, McKeown-Eyssen G, Karagas MR, Baron JA Tags: Br J Dermatol Source Type: research